Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of NVP-BHG712 treatment on gene expression of BMMs differentiating into osteoclasts.

ABSTRACT: Effect of NVP-BHG712 treatment on gene expression of BMMs differentiating into osteoclasts.

PROVIDER: PRJNA1086539 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Effect of NVP-BHG712 treatment on gene expression of BMMs differentiating into osteoclasts.

Project description:To investigate the effect of NVP-BHG712 on osteoclast differentiation, BMMs were removed from femorae of C57BL/6 mice and treated with NVP-BHG712 for RNA-seq

2024-12-01 | GSE261350 | GEO

Expression profiles of BMMs and osteoclasts

Project description:Expression profiles of BMMs and osteoclasts

| PRJNA987598 | ENA

High-throughput sequencing analysis of BMMs and BMMs-derived osteoclasts

Project description:High-throughput sequencing analysis of BMMs and BMMs-derived osteoclasts

| PRJNA555428 | ENA

The gene expression profile of primary BMMs differentiating into osteoclasts after knockout of solute carrier family 11 member 2 (SLC11A2)

Project description:The gene expression profile of primary BMMs differentiating into osteoclasts after knockout of solute carrier family 11 member 2 (SLC11A2)

| PRJNA1194049 | ENA

Proteomic Study of Different Culture Medium Serum Volume Fractions on RANKL-dependent Differentiating into Osteoclasts of RAW264.7 Cells

Project description:Supplemental data for the article: Proteomic Study of Different Culture Medium Serum Volume Fractions on RANKL-dependent Differentiating into Osteoclasts of RAW264.7 Cells

2015-06-02 | PXD001935 | Pride

Effect of Hairy and Enhancer of Split 1 (HES1) activation on gene expression of mature osteoclasts

Project description:To investigate the role of HES1 in osteoclast differentiation and function, bone marrow-derived macrophages (BMMs) were derived from CtskCre/WT;RosaHes1 and control (Rosa[STOP]Hes1 ) mice and were differentiated into mature osteoclasts. We then performed gene expression profiling analysis using data obtained from RNA-seq of conrol and HES1-overexpressing osteoclasts.

2022-07-01 | GSE207120 | GEO

Expression profiles of BMMs and osteoclasts

Project description:To profile the overall transcriptomic changes, we performed RNA-seq with bone marrow macrophages (BMM) before and after osteoclast differentiation (day 0 vs day 4). To induce mature osteoclasts formation, BMM were seeded and culture with customized αMEM containing 1/50 CMG14-12 supernatant and 75 ng/ml RANKL for 4 days.

2024-01-31 | GSE235773 | GEO

The gene expression profile of primary BMMs differentiating into osteoclasts after knockout of solute carrier family 11 member 2 (SLC11A2)

Project description:To investigate the effect of solute carrier family 11 member 2 (SLC11A2) knockout on osteoclast differentiation, BMMs were extracted from the femurs of SLC11A2 knockout mice and the same litter of control mice, treated with RANKL, and then rna sequencing was performed.

2024-12-15 | GSE283491 | GEO

High-throughput sequencing analysis of BMMs and BMMs-derived osteoclasts

Project description:Long noncoding RNAs (lncRNAs) have emerged as integral regulators of physiology and disease, but specific roles of lncRNAs in bone resorption remain largely unknown. Here, RNA-seq analysis indicated that lncRNA Nron was a candidate funtional regulators of bone resorption. Our further experimental analysis showed that Nron regulates bone resorption in mice. We further identified a functional motif of Nron. Consequently, delivery of Nron functional motif specifically in osteoclasts reversed bone loss without obvious side-effects in vivo. Together, our study indicate that Nron is a key bone resorption suppressor and reveal Nron functional motif might be a potential therapeutic strategy to combat excessive bone absorption in osteoporosis.

2019-07-19 | GSE134457 | GEO

Effect of BMS-582949 treatment on gene expression in osteoclasts

Project description:Effect of BMS-582949 treatment on gene expression in osteoclasts

| PRJNA1051041 | ENA